Protracted COVID-19 pneumonia in B-cell-depleted patients
Authors:
Open Access
- 23 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (4) , 2303-2305
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityJCI Insight, 2024
- Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trialAnnals of the Rheumatic Diseases, 2023
- T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19Science Translational Medicine, 2023
- Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike ProteinClinical Infectious Diseases, 2023